News
July 21, 2021
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit
July 15, 2021
TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering
May 27, 2021
TScan Therapeutics Adds to Executive Leadership Team and Board of Directors
March 23, 2021
TScan Therapeutics Appoints Katina Dorton, J.D., M.B.A., to Its Board of Directors
February 23, 2021
TScan Therapeutics Strengthens Leadership Team with the Appointment of Brian M. Silver as Chief Financial Officer
January 25, 2021
TScan Therapeutics Announces $100 Million Series C Financing
January 8, 2021
TScan Therapeutics Appoints Brian M. Silver, J.D., to Its Board of Directors
January 6, 2021
TScan Therapeutics Announces Presentation at the 39th Annual J.P. Morgan Healthcare Conference
November 10, 2020
TScan Therapeutics Announces Partnership with QIAGEN to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response
November 9, 2020